Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Artivion (AORT) Shares Outstanding (Weighted Average) (2016 - 2025)

Artivion's Shares Outstanding (Weighted Average) history spans 17 years, with the latest figure at $45.3 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 8.78% year-over-year to $45.3 million; the TTM value through Dec 2025 reached $45.3 million, up 8.78%, while the annual FY2025 figure was $45.3 million, 8.78% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $45.3 million in Q4 2025 per AORT's latest filing, down from $47.2 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $47.2 million in Q3 2025 to a low of $38.7 million in Q1 2021.
  • Average Shares Outstanding (Weighted Average) over 5 years is $41.1 million, with a median of $40.7 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Weighted Average): grew 1.46% in 2023, then grew 13.52% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $39.0 million in 2021, then grew by 2.69% to $40.0 million in 2022, then grew by 1.78% to $40.7 million in 2023, then grew by 2.29% to $41.7 million in 2024, then rose by 8.78% to $45.3 million in 2025.
  • Per Business Quant, the three most recent readings for AORT's Shares Outstanding (Weighted Average) are $45.3 million (Q4 2025), $47.2 million (Q3 2025), and $43.3 million (Q2 2025).